Inactive Instrument

Highlights Abiomed, Inc.

Equities

ABMD

US0036541003

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium	23/23/23	CI
Johnson & Johnson Closes Acquisition of Abiomed	22/22/22	MT
Johnson & Johnson completed the acquisition of Abiomed, Inc..	22/22/22	CI
Abiomed Says US FDA Approves Impella ECP Pivotal Heart Pump	21/22/21	MT
Abiomed Announces United States Food and Drug Administration Approves Version of Impella ECP	21/22/21	CI
Steel Dynamics to Join S&P 500; Super Micro Computer to be Added to S&P MidCap 400	20/22/20	MT
Johnson & Johnson Extends Abiomed Tender Offer to Dec. 21	14/22/14	MT
Abiomed, Inc. Announces First Patients in the World Treated with Impella Rp Flex with Smartassist	05/22/05	CI
Tranche Update on Abiomed, Inc.'s Equity Buyback Plan announced on August 1, 2019.	04/22/04	CI
Tranche Update on Abiomed, Inc.'s Equity Buyback Plan announced on August 4, 2022.	04/22/04	CI
Trending : Johnson & Johnson to Buy Abiomed	01/22/01	DJ
Johnson & Johnson Strikes $16.6 Billion Deal to Buy Heart-Device Maker Abiomed	01/22/01	MT
Abiomed Posts Higher Fiscal Q2 Adjusted Earnings, Revenue	01/22/01	MT
Earnings Flash (ABMD) ABIOMED Reports Q2 Revenue $265.9M, vs. Street Est of $272.8M	01/22/01	MT
Earnings Flash (ABMD) ABIOMED Posts Q2 EPS $1.30, vs. Street Est of $1.03	01/22/01	MT
Abiomed, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	01/22/01	CI
Johnson & Johnson to Buy Abiomed For $380 per Share	01/22/01	MT
J&J to buy Abiomed in $16.6 billion deal	01/22/01	RE
Johnson & Johnson entered into a definitive agreement to acquire Abiomed, Inc. for $17.4 billion.	01/22/01	CI
Abiomed Gets FDA Nod for Impella RP Flex with SmartAssist to Treat Right Heart Failure	31/22/31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Abiomed, Inc.

Equities

ABMD

US0036541003

Highlights

Filters